Literature DB >> 15058782

Integrating health profile with survival for quality of life assessment.

Jing-Shiang Hwang1, Jung-Der Wang.   

Abstract

In cohort studies or clinical trials, measurements of quality of life (QoL) were averaged across available individuals for each group at given points in time to produce single measures for comparisons. However, estimates of these single measures may be severely biased if substantial mortality occurs over time. The objective of this study is to develop a method that integrates QoL measurement and survival for long-term evaluation of health services. We defined a mean QoL score function over time for an index population as the average QoL score of all individuals both alive and dead at each time point in the population. While a living subject's QoL can be assessed by asking one's subjective preference, the score of a decedent can be assigned a fixed value depending on the specific facet on health profile. The mean QoL score function over time is reduced to a single measure of expected cumulative QoL score, which is the area under the curve of mean QoL score function over a given time interval and can be estimated by taking a random sample from a cross-sectional survey. For the QoL score function to be extrapolated to life-long, it requires the assumption that the disease causes premature death or a long-term moderate impairment of QoL. We provided methods and computer programs for estimating mean QoL score functions and the reduced single measures for use in comparisons. A cohort of 779 breast cancer patients from Chiangmai, Thailand were followed for 12 years to demonstrate the proposed methods. The data included the 12-year complete survival records and QoL scores on 233 patients collected from a cross-sectional survey using WHOQOL questionnaire and standard gamble method. The expected cumulative QoL scores using utility and psychometric scales were compared among patients in four groups of clinical stages in this cohort for time from onset up to 12 years and life-long. We conclude that such an integration of QoL measurement with survival can be useful for the evaluation of health service and clinical decision.

Entities:  

Mesh:

Year:  2004        PMID: 15058782     DOI: 10.1023/B:QURE.0000015299.45623.38

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  5 in total

1.  Monte Carlo estimation of extrapolation of quality-adjusted survival for follow-up studies.

Authors:  J S Hwang; J D Wang
Journal:  Stat Med       Date:  1999-07-15       Impact factor: 2.373

Review 2.  One thousand health-related quality-of-life estimates.

Authors:  T O Tengs; A Wallace
Journal:  Med Care       Date:  2000-06       Impact factor: 2.983

3.  Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group.

Authors: 
Journal:  Psychol Med       Date:  1998-05       Impact factor: 7.723

4.  Estimation of expected quality adjusted survival by cross-sectional survey.

Authors:  J S Hwang; J Y Tsauo; J D Wang
Journal:  Stat Med       Date:  1996-01-15       Impact factor: 2.373

5.  The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization.

Authors: 
Journal:  Soc Sci Med       Date:  1995-11       Impact factor: 4.634

  5 in total
  21 in total

1.  Estimating the impact of increasing cervical cancer screening in the National Breast and Cervical Cancer Early Detection Program among low-income women in the USA.

Authors:  Lisa M Pollack; Donatus U Ekwueme; Mei-Chuan Hung; Jacqueline W Miller; Su-Hsin Chang
Journal:  Cancer Causes Control       Date:  2020-05-20       Impact factor: 2.506

2.  Integrating health-related quality of life with sickness leave days for return-to-work assessment in traumatic limb injuries.

Authors:  Wen-Hsuan Hou; Huey-Wen Liang; Ching-Lin Hsieh; Ching-Fan Sheu; Jing-Shiang Hwang; Hung-Yi Chuang
Journal:  Qual Life Res       Date:  2013-02-08       Impact factor: 4.147

3.  Quality-adjusted life-years and helmet use among motorcyclists sustaining head injuries.

Authors:  Hsin-Yi Lee; Yeh-Hsin Chen; Wen-Ta Chiu; Jing-Shiang Hwang; Jung-Der Wang
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

4.  Lifetime medical expenditure and life expectancy lost attributable to smoking through major smoking related diseases in Taiwan.

Authors:  Chih-Wen Chung; Jung-Der Wang; Cheng-Fen Yu; Ming-Chin Yang
Journal:  Tob Control       Date:  2007-12       Impact factor: 7.552

5.  Health-related quality of life after first-line anti-cancer treatments for advanced non-small cell lung cancer in clinical practice.

Authors:  Szu-Chun Yang; Wu-Wei Lai; Tzuen-Ren Hsiue; Wu-Chou Su; Cheng-Kuan Lin; Jing-Shiang Hwang; Jung-Der Wang
Journal:  Qual Life Res       Date:  2015-11-07       Impact factor: 4.147

6.  Cost per QALY (quality-adjusted life year) and lifetime cost of prolonged mechanical ventilation in Taiwan.

Authors:  Mei-Chuan Hung; Hsin-Ming Lu; Likwang Chen; Ming-Shian Lin; Cheng-Ren Chen; Chong-Jen Yu; Jung-Der Wang
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

7.  Life expectancies and incidence rates of patients under prolonged mechanical ventilation: a population-based study during 1998 to 2007 in Taiwan.

Authors:  Mei-Chuan Hung; Hsin-Ming Lu; Likwang Chen; Fu-Chang Hu; Soa-Yu Chan; Yuan-Horng Yan; Po-Sheng Fan; Ming-Shian Lin; Cheng-Ren Chen; Lu-Cheng Kuo; Chong-Jen Yu; Jung-Der Wang
Journal:  Crit Care       Date:  2011-04-01       Impact factor: 9.097

8.  Estimation of Life-Year Loss and Lifetime Costs for Different Stages of Colon Adenocarcinoma in Taiwan.

Authors:  Po-Chuan Chen; Jenq-Chang Lee; Jung-Der Wang
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

9.  Incidence, life expectancy and prognostic factors in cancer patients under prolonged mechanical ventilation: a nationwide analysis of 5,138 cases during 1998-2007.

Authors:  Chih-Yuan Shih; Mei-Chuan Hung; Hsin-Ming Lu; Likwang Chen; Sheng-Jean Huang; Jung-Der Wang
Journal:  Crit Care       Date:  2013-07-22       Impact factor: 9.097

10.  Optimal Intervals of Ultrasonography Screening for Early Diagnosis of Hepatocellular Carcinoma in Taiwan.

Authors:  Shih-Chiang Kuo; Chia-Ni Lin; Yih-Jyh Lin; Wei-Ying Chen; Jing-Shiang Hwang; Jung-Der Wang
Journal:  JAMA Netw Open       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.